2015
DOI: 10.1016/j.ajo.2015.06.030
|View full text |Cite
|
Sign up to set email alerts
|

Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

19
226
0
7

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 305 publications
(252 citation statements)
references
References 25 publications
(29 reference statements)
19
226
0
7
Order By: Relevance
“…[16][17][18][19][20][21][22][23][24] The feeder vessel to the choroid in type 1 and 2 CNV and to the retinal vasculature in type 3 CNV may be visible when there is good signal and scan quality. 24,25 Polyps in eyes with PCV are not easily visualized using OCTA.…”
Section: Age-related Macular Degeneration and Choroidal Neovascularizmentioning
confidence: 99%
“…[16][17][18][19][20][21][22][23][24] The feeder vessel to the choroid in type 1 and 2 CNV and to the retinal vasculature in type 3 CNV may be visible when there is good signal and scan quality. 24,25 Polyps in eyes with PCV are not easily visualized using OCTA.…”
Section: Age-related Macular Degeneration and Choroidal Neovascularizmentioning
confidence: 99%
“…It has become an important clinical tool in ophthalmology [6][7][8][9][10][11][12][13][14] and exhibits great potential for dermatology [15,16] and neurology [17]. To obtain flow signal, OCTA algorithms [1,3,[18][19][20] rely on mathematical operations that quantify variations in the amplitude and/or the phase of optical coherence tomography (OCT) signal between at least two consecutive B-scans acquired at the same raster position.…”
Section: Introductionmentioning
confidence: 99%
“…OCTA has generated significant clinical interest as a label-free method of angiography, and a number of recent studies have investigated its potential in visualizing CNV in AMD. [3][4][5][6][7] Importantly, OCTA was shown to be able monitor changes in the CNV network over time in response to anti-vascular endothelial growth factor (anti-VEGF) treatment. [8][9][10] As a result, identification and quantification of the CNV network may have important clinical implications.…”
Section: Introductionmentioning
confidence: 99%